<DOC>
	<DOCNO>NCT00232167</DOCNO>
	<brief_summary>The goal study determine whether indiplon , administer sertraline , improve insomnia symptom depressive symptom subject insomnia depression .</brief_summary>
	<brief_title>Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression</brief_title>
	<detailed_description>This Pfizer run study stop due co-development program indiplon terminate Pfizer Neurocrine . The study terminate 16 November 2006 . There safety issue lead decision terminate study .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Indiplon</mesh_term>
	<criteria>DSMIV define insomnia DSMIV define Major Depression Current suicidal ideation behavior Primary sleep disorder insomnia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2007</verification_date>
</DOC>